Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

The Bull and Bear Cases for SOS Limited Stock

By Ian Bezek, InvestorPlace Contributor

There's a war going on in SOS stock. It appears to have a rapidly growing crypto business but short sellers disagree. Here's the bottom line.

GameStop’s Huge Squeeze Sets Up an Intriguing Bullish Options Trade

By Ian Bezek, InvestorPlace Contributor

GME stock is exceptionally risky right now. However, that risk isn't all bad. Due to extreme volatility, GameStop option sellers have a golden opportunity today.

Northern Dynasty’s Empire Is in Painful Decline

By Ian Bezek, InvestorPlace Contributor

Reddit traders have latched onto NAK stock. But the company's long-term looks dim as numerous politicians have opposed its flagship project.

A Name Change Won’t Fix the Disaster That Is Asensus Surgical

By Ian Bezek, InvestorPlace Contributor

TransEnterix is now Asensus Surgical. However, this is unlikely to improve sales for Asensus' floundering line of products. Thus, fade the pop in ASXC stock.

Sundial Growers Might Get Another Reddit Bump, but Don’t Hold Your Breath

By Ian Bezek, InvestorPlace Contributor

Don't buy the pullback in SNDL stock. Given the massive dilution here, shares have much further still to fall.

ARK Innovation ETF Is Worth Owning as Long as the Bull Market Continues

By Ian Bezek, InvestorPlace Contributor

The ARKK ETF has been one of the biggest winners over the past five years. It should continue to prosper, at least until the current tech boom fades.

7 Upcoming SPAC Mergers to Avoid

By Ian Bezek, InvestorPlace Contributor

The stock market has suddenly broken to the downside over the past two weeks. That makes these SPACs particularly risky bets as the momentum fades.

With Vaccine Distribution Profits Possible, Keep an Eye on Ocugen Stock

By Ian Bezek, InvestorPlace Contributor

Ocugen has partnered on development of a credible Covid-19 vaccine. This could work wonders for OCGN stock, but it's a race to get to market in time.

7 Cheap Stocks With a Great Comeback Story

By Ian Bezek, InvestorPlace Contributor

With the market looking expensive and shaky, it's time to pick through the discount bin. These seven comeback stocks could be just the right buys for now.

Ranking the Top 7 Marijuana Stocks From Best to Worst

By Ian Bezek, InvestorPlace Contributor

Marijuana stocks are volatile right now. Cut through the noise with this ranking of seven leaders from best to worst.

Load More